ArticleThe Journal of clinical endocrinology and metabolism2023

Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer-To Treat or Not to Treat.

Evert F S van Velsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.